Phase 2a Study Assessing Colonization Efficiency, Safety, and Acceptability of Lactobacillus crispatus CTV-05 in Women With Bacterial Vaginosis
Author(s) -
Anke Hemmerling,
W. G. Harrison,
Adrienne Schroeder,
Jeanna Park,
Abner Korn,
Stephen Shiboski,
Anne Foster-Rosales,
Craig R. Cohen
Publication year - 2010
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0b013e3181e50026
Subject(s) - medicine , bacterial vaginosis , placebo , tolerability , dysuria , lactobacillus crispatus , vaginal flora , adverse effect , vagina , lactobacillus , genitourinary system , vaginal disease , randomized controlled trial , gynecology , urinary system , surgery , alternative medicine , pathology , biology , bacteria , genetics
Bacterial vaginosis (BV) is a common vaginal infection caused by a lack of endogenous lactobacilli and overgrowth of pathogens that frequently recurs following antibiotic treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom